CLASS 2 RECALL - COLD & FLU RELIEF CAPSULES (GSL) – VARIOUS LIVERIES

Perrigo are recalling the below batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products as noted above. The leaflet and carton incorrectly states that for Adults, the elderly and children 12 years and over, the dose should be 2 capsules every 4 to 6 hours as required, up to a maximum of 12 capsules in any 24 hour period. The leaflet and carton dosage instructions are those which were in use prior to the paediatric paracetamol posology update implemented by the MHRA

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-cold-and-flu-relief-capsules-gsl-various-liveries-wrafton-laboratories-limited-trading-as-perrigo-el-21-a-slash-28?utm_medium=email&utm_campaign=govuk-notifications&utm_source=f44f6fc5-9c7f-4cc3-b3ab-df07db229afc&utm_content=immediately   

Further Information

For more information, please contact: Perrigo Customer Services Team on 0203 598 9603 or UKLOCustomerService@perrigo.com

For stock control queries, please contact: Perrigo Service Team on 01226 704711 or customerservice@perrigouk.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

Alliance Healthcare partners with Novo Nordisk for the launch of PenCycle; the circular recycling initiative

Alliance Healthcare UK is delighted to collaborate with Novo Nordisk to help reduce plastic pen devices entering UK landfills by up to 1.1 million in the next year.

Novo Nordisk, a global healthcare company specialising in treatments for people living with diabetes, obesity, and rare blood and endocrine disorders, has launched PenCycle; the circular recycling initiative for pre-filled diabetes and weight management pens. As a partner organisation, Alliance Healthcare will be delivering all the materials needed to recycle the pre-filled injection pen devices, including a blue PenCycle Recycling Bin, PenCycle Return Boxes and other support materials to Community pharmacy. These materials are being provided completely free of charge by Novo Nordisk. 

A first-of-its-kind in the UK, the PenCycle Pilot has launched across Greater Manchester, Leicestershire & Rutland, and Greater Glasgow and Clyde, ahead of a planned national roll-out next year. Selected pharmacies in these areas have been invited to participate to show their support towards the environmental target, and upon sign up of the scheme, will play a big role in helping to reduce waste and advance the sustainability agenda of community pharmacy.

Skills in Healthcare has led participation in the project on behalf of Alliance Healthcare, from initial discussions with Novo Nordisk to the official launch which happened on 1st November. Skills in Healthcare will now support pharmacy engagement and on boarding of pharmacies to the scheme.

Paul Fowler, Head of Skills in Healthcare, presented at the launch event and said: “We are delighted to be partnered with Novo Nordisk, supporting the design and delivery of the PenCycle Recycling Pilot within a pharmacy setting. The process has been designed to be simple to manage and allows a pharmacy to participate by using all the systems and processes they are already familiar with. It provides their patients with a new pharmacy return option and supports them to recycle their Novo Nordisk Insulin pens. I hope all the pharmacies in the pilot areas will participate and help make PenCycle a real success story. “

As a central point of care, community pharmacies will be key to the success of this forward-thinking initiative, and Alliance Healthcare are delighted to play a part of it.

Pharmacies located in the relevant pilot areas are encouraged to join the scheme by visiting: https://www.alliance-healthcare.co.uk/pencycle.

For more information, you can contact the Skills in Healthcare PenCycle team at: PenCycle@skills-in-healthcare.co.uk

About Skills in Healthcare

Skills in Healthcare is a contract sales and marketing business that provides customers with flexible and cost-effective solutions to realise retail pharmacy potential. With over 70 years’ experience in retail pharmacy, Skills in Healthcare provides a wide range of services including dynamic sales support, training, consulting, call centre and branding support.

To find out more visit: https://www.skills-in-healthcare.co.uk/

Class 4 Drug Caution in use - MITOCIN (MITOMYCIN) 20MG POWDER FOR SOLUTION FOR INJECTION/INFUSION

Vygoris Limited has informed the MHRA that some vials of Mitocin 20mg powder for solution for injection/infusion or intravesical use may contain subvisible particles above the current specifications after reconstitution (>10µm: NMT 6000/vial), initially identified during stability studies. Vygoris Limited has confirmed that a single-use filtration device called the Millex® HV (0.45 μm/PVDF) - Syringe Filter will be included in each delivery of the product

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-vygoris-limited-mitocin-mitomycin-20mg-powder-for-solution-for-injection-slash-infusion-or-intravesical-use-el-21-a-slash-27?utm_medium=email&utm_campaign=govuk-notifications&utm_source=23f29568-2411-48f9-bc43-7b69aed25c18&utm_content=immediately                  

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries, please contact:

Lucy Owen,

ProductLifeGroup

Tel: +44 (0) 1223 402660

Email: lowen@productlife-group.com

For more information or stock control queries, please contact:

Hussain Tahan

Vygoris Ltd

Tel: 020 3865 1682

Email: qualitylimited@vygoris.com

If you have any questions, then please contact your local Service Centre Customer Services team

Alliance Healthcare Celebrates Diwali

At Alliance Healthcare, we recognise Diwali as part of our continued commitment to help make all team members feel part of a diverse and inclusive workplace, as we showcase the colour, vibrancy and excitement of Diwali.

Julian Mount, Managing Director calls for a time for reflection in the current ‘Shining a light for Diwali’ article by Pharmacy Business.

A time for reflection: Julian Mount

“Diwali is a time for celebration, and a time for reflection. It is important that we take a moment to stop and enjoy Diwali, and to recognise the incredible dedication and commitment each pharmacy team member has shown to UK patients and our society, during these difficult times.

“Your unwavering resilience in the fight against Covid-19 is something all those in community pharmacy should feel extremely proud about. At Alliance Healthcare, we recognise Diwali as part of our continued commitment to help make all team members feel part of a diverse and inclusive workplace, as we showcase the colour, vibrancy and excitement of Diwali.

Julian Mount, managing director, Alliance Healthcare

“My teams are encouraged to dress in their traditional clothing and share their stories, as together, we mark this special occasion. In the world’s largest Diwali celebrating community – India, Alliance Healthcare has supported the AWARE Foundation and Vitamin Angels charities, with their efforts to reach children in deprived communities throughout India and beyond, to not only eliminate malnutrition but to transform their lives for the better.

“I would like to personally thank you for your passion and care in everything you all do for our society. I wish you all a Diwali that brings happiness, prosperity and joy to you, your teams and all your loved ones.”

You can read the ‘Shining a light for Diwali’ article by Pharmacy Business here:

https://www.pharmacy.biz/long-read-shining-a-light-for-diwali/

CLASS 4 CAUTION IN USE - SYRENIRING 0.12MG/0.015MG 24 HR

Crescent Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the below batches is missing important safety relevant text changes

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-crescent-pharma-ltd-syreniring-0-120-mg-0-015-mg-per-24-hours-vaginal-delivery-system-el-20-a-36?utm_medium=email&utm_campaign=govuk-notifications&utm_source=8b7c3acf-aee7-4d91-8b27-85a8e19f72c8&utm_content=immediately               

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will  be required to follow the instructions as per the drug alert.

This is a caution in use only we are not accepting stock returns.

For more information or medical information queries, please contact: Crescent Pharma Ltd. Medical Information Department on +00351 214643225, via email on tiago.barca@pharsolution.com or +44 (0) 1256 772740..

If you have any questions, then please contact your local Service Centre Customer Services team.

Alliance Healthcare UK becomes one of four partner wholesalers in agreement with Sanofi UK 01 November 2021

We would like to inform you that Sanofi UK has chosen to partner with Alliance Healthcare UK to optimise supply of its products and services to the Independent Pharmacy sector.

Sanofi UK has now partnered with four national UK Pharmacy Wholesalers to supply all Sanofi UK consumer healthcare products to the Independent Pharmacy sector, hospitals, and other healthcare outlets.

As a partner wholesaler to Sanofi UK, we, Alliance Healthcare Ltd are delighted to continue to promote Sanofi UK products, offering support on ranging, merchandising, recommendation and key category insights via monthly promotional magazines and online platforms.

Sanofi UK will continue its support to Community Pharmacies via the Sanofi Field and Telesales teams using the following assets:

• - Transfer Orders
• - Point of Sale activation
• - Staff Training & Education Resources
• - Digital Assets
• - Seasonal Promotional Offers (via Wholesaler of their choice)

A further four product lines will become available to purchase with Alliance Healthcare as part of the new agreement. See below list of new products:

PIP                    Description

022-8338          PROCTOSEDYL SUPPS X12 GB

022-8312           PROCTSEDYL OINT 30G

095-3141            SOLPADOL 500 MG 100 CAPLETS

090-3708          SOLPADOL EFF TABS 100S

For your convenience, details of the Sanofi UK portfolio have been listed here.

Purchases of the Sanofi UK portfolio will arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation they will not be subject to Alliance Healthcare’s low spend or fuel surcharges.

To receive the products from 01 November 2021, you can simply order from Alliance Healthcare in your usual manner. There will be no changes to the delivery service for Sanofi UK products through Alliance Healthcare.

If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.

CLASS 3 RECALL - BIMATOPROST ASPIRE 0.3MG/ML EYE DROPS, SOLUTION IN SINGLE DOSE CONTAINER 0.4ML X 30

Aspire Pharma Limited is recalling the below batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure due to the identification of some variability in the thickness of plastic of the single dose containers resulting in some patients finding the containers difficult to squeeze due to increased hardness of individual containers

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-bimatoprost-aspire-0-dot-3mg-slash-ml-eye-drops-solution-in-single-dose-container-aspire-pharma-limited-el-21-a-slash-26?utm_medium=email&utm_campaign=govuk-notifications&utm_source=c124cb76-bb49-44e5-be21-df3473e3acd9&utm_content=immediately  

Further Information

For more information please contact:

Customer Services for stock control enquiries:

Email: customerservices@aspirepharma.co.uk

Tel. 01730 231148

or for Medical Information enquiries:

Email: medinfo@aspirepharma.co.uk

Tel. 01730 231148

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

Championing Community Pharmacy

Julian Mount, Managing Director, Alliance Healthcare joins industry leadership panel to discuss the future of pharmacy at the Pharmacy Business Conference 2021.

When asked about how community pharmacy can build on the current public goodwill rating, Julian highlighted the great work done by community pharmacy, but also the need going forward for a joined-up approach when lobbying for further support: “I have been blown away by the effort everyone has put in during the COVID crisis, the trust score really highlights what is happening at grassroots level. When I see the passion, drive, and energy, it has been phenomenal” Julian went on to add: “What needs to happen next is we need to see a united, more data driven unified approach to make the government sit up and listen and further support community pharmacy to allow them to take advantage of the great work done throughout COVID -19.”

We’ve created a 10-minute highlights video from the event that can be seen below.

COMPANY LED - IRINOTECAN 200MG/ 260ML IN SODIUM CHLORIDE 0.9% W/V INTRAVENOUS INFUSION AND INFLIXIMAB (REMSIMA) INTRAVENOUS INFUSION IN SODIUM CHLORIDE 0.9%

Qualasept Ltd t/a Bath ASU is recalling a specific batch of Irinotecan 200mg/260mL in sodium chloride 0.9% w/v intravenous infusion and specific batches of Infliximab (Remsima) Intravenous infusion in Sodium Chloride 0.9%w/v due to risks of reduced product quality

MHRA drug alert link https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-irinotecan-200mg-slash-260ml-in-sodium-chloride-0-dot-9-percent-w-slash-v-intravenous-infusion-and-infliximab-remsima-intravenous-infusion-in-sodium-chloride-0-dot-9-percent?utm_medium=email&utm_campaign=govuk-notifications&utm_source=46e56b1e-074c-4df7-b8da-04593bef0bdc&utm_content=immediately     

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

Company Contact for medical information enquiries

For medical information enquiries, please contact Maria Connolly:

Tel: 01225 811131

Maria.connolly@bathasu.com

Company Contact for stock enquiries

For stock information enquiries,

Tel: 01225 811131

customerservices@bathasu.com

Alliance Healthcare supports the AWARE Foundation at annual Golf Day event

As part of our continued efforts to help young people, our team recently supported the AWARE Foundationwith its annual Golf Day event at Langley Park Golf Club. The AWARE Foundation helps disadvantaged, vulnerable children in India by providing them with an education to transform their lives for the better.

The event saw 120 delegates take part in the golf tournament where 32 teams competed to win numerous categories, in an effort to help raise much needed funds. Alliance Healthcare supported the fundraising event by donating prizes that were put into the evening raffle and auction. Ashley Kilgas, Sales Director represented the business, saying “It’s great to be back attending these charity events to support an amazing cause. We have a fantastic relationship with the AWARE Foundation, and I am excited to see how our partnership will grow even stronger.”

The golf day was a huge success and raised an incredible £28,682. Jayesh Patel, Founder/Managing Trustee of the AWARE Foundation commented: “AWARE helps thousands of children each year, and this is only possible because of the dedicated support that we have - Alliance Healthcare being one of our most fundamental ones. So thank you so much again for your support, and we look forward to working with and seeing you all again soon.”

To find out more about the AWARE foundation, you can click the following link here.